WO2001079246A2
(en)
|
2000-04-13 |
2001-10-25 |
Pharmasset, Ltd. |
3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EA200601591A1
(ru)
|
2000-05-26 |
2007-02-27 |
Айденикс (Кайман) Лимитед |
Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
|
AU2002243791B2
(en)
|
2001-01-22 |
2006-06-29 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
GB0114286D0
(en)
*
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US7138376B2
(en)
*
|
2001-09-28 |
2006-11-21 |
Idenix Pharmaceuticals, Inc. |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
|
EP1438054A4
(en)
*
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
JPWO2003068796A1
(ja)
*
|
2002-02-15 |
2005-06-02 |
ヤマサ醤油株式会社 |
4’−c−シアノ−2’−デオキシプリンヌクレオシド
|
US20070010489A1
(en)
|
2002-04-26 |
2007-01-11 |
Arimilli Murty N |
Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
BR0312278A
(pt)
*
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
US20050058982A1
(en)
|
2002-07-26 |
2005-03-17 |
Chiron Corporation |
Modified small interfering RNA molecules and methods of use
|
US20040067877A1
(en)
|
2002-08-01 |
2004-04-08 |
Schinazi Raymond F. |
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
|
BR0313164A
(pt)
|
2002-08-01 |
2007-07-17 |
Pharmasset Inc |
compostos com o sistema biciclo[4.2.1] nonano para o tratamento de infecções por flaviviridae
|
DK1576138T3
(en)
|
2002-11-15 |
2017-05-01 |
Idenix Pharmaceuticals Llc |
2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
|
TWI332507B
(en)
*
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
TWI294882B
(en)
*
|
2002-12-09 |
2008-03-21 |
Hoffmann La Roche |
Anhydrous crystalline azido cytosine hemisulfate derivative
|
US7598373B2
(en)
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
US20040181051A1
(en)
*
|
2002-12-23 |
2004-09-16 |
Richard Storer |
Process for the production of 3'-nucleoside prodrugs
|
AU2003300544A1
(en)
*
|
2003-01-09 |
2004-08-10 |
F. Hoffmann-La Roche Ag |
-modified nucleoside derivatives for treating flaviviridae infections
|
WO2005011709A1
(en)
*
|
2003-02-19 |
2005-02-10 |
Yale University |
Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
|
BRPI0408846A
(pt)
*
|
2003-03-28 |
2006-07-04 |
Pharmasset Inc |
compostos para o tratamento de infecções por flaviviridae
|
US7294877B2
(en)
*
|
2003-03-28 |
2007-11-13 |
Nantero, Inc. |
Nanotube-on-gate FET structures and applications
|
NZ542342A
(en)
|
2003-04-25 |
2009-05-31 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
JP2006524710A
(ja)
|
2003-04-25 |
2006-11-02 |
ギリアード サイエンシーズ, インコーポレイテッド |
キナーゼインヒビターホスホネート抱合体
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
EP2345658A1
(en)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
MXPA05013452A
(es)
*
|
2003-06-19 |
2006-03-09 |
Hoffmann La Roche |
Proceso para preparar derivados de 4'-azidonucleosido.
|
PT1658302E
(pt)
|
2003-07-25 |
2010-10-25 |
Centre Nat Rech Scient |
Análogos do nucleósido purina para o tratamento de doenças provocadas por flaviviridae incluindo hepatite c
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
AU2004286239A1
(en)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
KR20060127906A
(ko)
*
|
2003-12-22 |
2006-12-13 |
길리애드 사이언시즈, 인코포레이티드 |
4'-치환된 카보버와 아바카비어 유도체 및 hiv와 hcv항바이러스 활성을 갖는 관련 화합물
|
US20050182252A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
EA200901463A1
(ru)
|
2004-02-20 |
2010-08-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Ингибиторы вирусной полимеразы
|
WO2005123087A2
(en)
|
2004-06-15 |
2005-12-29 |
Merck & Co., Inc. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
US20070265222A1
(en)
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
EP3539546A1
(en)
|
2004-07-27 |
2019-09-18 |
Gilead Sciences, Inc. |
Phosphonate analogs of hiv inhibitor compounds
|
CN101044151B
(zh)
*
|
2004-08-23 |
2011-01-19 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-叠氮基-核苷
|
RU2433124C2
(ru)
|
2004-09-14 |
2011-11-10 |
Фармассет, Инк. |
Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
|
US7524831B2
(en)
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
AU2006242475B2
(en)
|
2005-05-02 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
AR057456A1
(es)
|
2005-07-20 |
2007-12-05 |
Merck & Co Inc |
Inhibidores de la proteasa ns3 del vhc
|
MX2008001588A
(es)
|
2005-08-01 |
2008-02-19 |
Merck & Co Inc |
Inhibidores de proteasa ns3 del vhc.
|
WO2007022073A2
(en)
*
|
2005-08-12 |
2007-02-22 |
Merck & Co., Inc. |
Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
|
WO2007020193A2
(en)
*
|
2005-08-15 |
2007-02-22 |
F. Hoffmann-La Roche Ag |
Antiviral phosphoramidates of 4 ' -substituted pronucleotides
|
ES2422290T3
(es)
|
2005-12-23 |
2013-09-10 |
Idenix Pharmaceuticals Inc |
Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
JP2009541436A
(ja)
*
|
2006-06-27 |
2009-11-26 |
ビオヴィトルム・アクチボラゲット(プブリクト) |
治療用化合物
|
DK2084175T3
(da)
*
|
2006-10-10 |
2011-04-18 |
Medivir Ab |
HCV nucleosidinhibitor
|
WO2008051477A2
(en)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
EP2079480B1
(en)
|
2006-10-24 |
2013-06-05 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
US8138164B2
(en)
|
2006-10-24 |
2012-03-20 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
CN101568346B
(zh)
|
2006-10-27 |
2015-11-25 |
默沙东公司 |
Hcv ns3蛋白酶抑制剂
|
RU2468029C2
(ru)
|
2006-10-27 |
2012-11-27 |
Иституто Ди Ричерке Ди Биолоджиа Молеколаре П.Анджелетти С.П.А. |
Ингибиторы hcv ns3 протеазы
|
WO2008071571A1
(en)
*
|
2006-12-11 |
2008-06-19 |
F. Hoffmann-La Roche Ag |
Process for preparation of 4'-azido cytidine derivatives
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CA2672250C
(en)
|
2006-12-20 |
2013-04-30 |
Ian Stansfield |
Antiviral indoles
|
US20080261913A1
(en)
*
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
CA2673649A1
(en)
|
2007-01-05 |
2008-07-17 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
WO2008101867A1
(en)
*
|
2007-02-19 |
2008-08-28 |
Smithkline Beecham Corporation |
Purine derivatives as immunomodulators
|
JP2010520200A
(ja)
*
|
2007-02-28 |
2010-06-10 |
クオナトウス ファーマシューティカルズ,インコーポレイテッド |
特定のマトリックスメタロプロテイナーゼ(mmp)阻害剤を使用する肝疾患を治療する方法
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
CA2685748A1
(en)
*
|
2007-05-14 |
2008-11-14 |
Rfs Pharma, Llc. |
Azido purine nucleosides for treatment of viral infections
|
GB0709791D0
(en)
*
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
CN100532388C
(zh)
*
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
WO2009010783A1
(en)
|
2007-07-17 |
2009-01-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Macrocyclic indole derivatives for the treatment of hepatitis c infections
|
AU2008277377B2
(en)
|
2007-07-19 |
2013-08-01 |
Msd Italia S.R.L. |
Macrocyclic compounds as antiviral agents
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
AR069740A1
(es)
*
|
2007-11-29 |
2010-02-17 |
Metabasis Therapeutics Inc |
Compuestos nucleosidos antivirales
|
US8461107B2
(en)
|
2008-04-28 |
2013-06-11 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
AR072428A1
(es)
*
|
2008-07-01 |
2010-08-25 |
Medivir Ab |
Derivados de pirimidin nucleotidos inhibidores de polimerasas del virus de la hepatitis c (vhc), composiciones farmaceuticas que los contienen y metodo para prepararlos.
|
CA2729168A1
(en)
|
2008-07-02 |
2010-02-04 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
AU2009268681B2
(en)
|
2008-07-08 |
2014-10-02 |
Gilead Sciences, Inc. |
Salts of HIV inhibitor compounds
|
US20100029655A1
(en)
*
|
2008-07-11 |
2010-02-04 |
Martin Robert Leivers |
Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
|
BRPI0916235B8
(pt)
|
2008-07-22 |
2021-05-25 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso do composto ou da composição
|
EP2326646B1
(en)
*
|
2008-08-11 |
2013-07-31 |
GlaxoSmithKline LLC |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
JP2011530562A
(ja)
*
|
2008-08-11 |
2011-12-22 |
グラクソスミスクライン エルエルシー |
アレルギー性、炎症性及び感染性疾患治療用のプリン誘導体
|
US8802684B2
(en)
|
2008-08-11 |
2014-08-12 |
Glaxosmithkline Llc |
Adenine derivatives
|
HUE033645T2
(en)
*
|
2008-08-11 |
2017-12-28 |
Glaxosmithkline Llc |
New adenine derivatives
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
US8815829B2
(en)
|
2008-12-09 |
2014-08-26 |
Rfs Pharma, Llc |
3′-azido purine nucleotide prodrugs for treatment of viral infections
|
PA8855801A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Sintesis de nucleosidos de purina
|
EP2376514A2
(en)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Nucleoside analogs
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
WO2010082050A1
(en)
|
2009-01-16 |
2010-07-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
EP2393815A4
(en)
|
2009-02-06 |
2012-11-21 |
Rfs Pharma Llc |
PURIN NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR THE TREATMENT OF CANCER AND VIRUS INFECTIONS
|
US8193372B2
(en)
|
2009-03-04 |
2012-06-05 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
WO2011014487A1
(en)
|
2009-07-30 |
2011-02-03 |
Merck Sharp & Dohme Corp. |
Hepatitis c virus ns3 protease inhibitors
|
US20110027229A1
(en)
|
2009-07-31 |
2011-02-03 |
Medtronic, Inc. |
Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
|
EP2461811B1
(en)
|
2009-08-05 |
2016-04-20 |
Idenix Pharmaceuticals LLC. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
US20110117055A1
(en)
|
2009-11-19 |
2011-05-19 |
Macdonald James E |
Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
|
EP2513113B1
(en)
|
2009-12-18 |
2018-08-01 |
Idenix Pharmaceuticals LLC |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
RU2556991C2
(ru)
*
|
2010-01-28 |
2015-07-20 |
Рибосайенс Ллк |
4'-азидонуклеозиды, активные в отношении hcv
|
WO2011098451A1
(en)
|
2010-02-10 |
2011-08-18 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
US9433621B2
(en)
|
2010-02-18 |
2016-09-06 |
Merck Sharp & Dohme Corp. |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
US8859756B2
(en)
|
2010-03-31 |
2014-10-14 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorus containing actives
|
UY33312A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Fosforamidato de nucleosido de purina
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
US8877731B2
(en)
|
2010-09-22 |
2014-11-04 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
MX2013003153A
(es)
|
2010-09-22 |
2013-05-01 |
Alios Biopharma Inc |
Analogos de nucleotidos sustituidos.
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
WO2012109398A1
(en)
|
2011-02-10 |
2012-08-16 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
PE20140522A1
(es)
|
2011-04-13 |
2014-05-03 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
EP2696679B1
(en)
|
2011-04-13 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
EP2731433A4
(en)
|
2011-07-13 |
2014-12-31 |
Merck Sharp & Dohme |
5'-SUBSTITUTED NUCLEOSIDE ANALOGUES AND METHODS OF USE FOR THE TREATMENT OF VIRAL DISEASES
|
WO2013009735A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
LT2734186T
(lt)
|
2011-07-22 |
2018-12-10 |
Glaxosmithkline Llc |
Kompozicija
|
EP2755983B1
(en)
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2755985B1
(en)
|
2011-09-12 |
2017-11-01 |
Idenix Pharmaceuticals LLC |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
KR101991298B1
(ko)
|
2011-09-16 |
2019-06-21 |
길리애드 파마셋 엘엘씨 |
Hcv 치료 방법
|
WO2013056046A1
(en)
|
2011-10-14 |
2013-04-18 |
Idenix Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2780026B1
(en)
|
2011-11-15 |
2019-10-23 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CN104185420B
(zh)
|
2011-11-30 |
2017-06-09 |
埃默里大学 |
用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
|
WO2013090420A2
(en)
*
|
2011-12-12 |
2013-06-20 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid antiviral conjugates and their uses
|
JP6118336B2
(ja)
*
|
2011-12-20 |
2017-04-19 |
リボサイエンス・エルエルシー |
Hcvのrna複製の阻害剤としての4’−アジド、3’−フルオロ置換されたヌクレオシド誘導体
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
AP2014007796A0
(en)
|
2011-12-22 |
2014-07-31 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
US20130217644A1
(en)
|
2012-02-13 |
2013-08-22 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013142124A1
(en)
|
2012-03-21 |
2013-09-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
AP3913A
(en)
|
2012-05-22 |
2016-11-26 |
Idenix Pharamaceuticals Inc |
D-amino acid compounds for liver disease
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
EP2861611B1
(en)
|
2012-05-25 |
2016-07-13 |
Janssen Sciences Ireland UC |
Uracyl spirooxetane nucleosides
|
MX2015001935A
(es)
*
|
2012-08-13 |
2015-06-22 |
Fujifilm Corp |
Intermediario para sintesis de 1-(2-desoxi-2-fluoro-4-tio-beta-d-a rabinofuranosil) citosina, intermediario para sintesis de tionucleosido y metodos para producir estos intermediarios.
|
US9173872B2
(en)
|
2012-08-24 |
2015-11-03 |
Glaxosmithkline Llc |
Pyrazolopyrimidine compounds
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
EA030189B8
(ru)
|
2012-10-08 |
2018-10-31 |
Иденикс Фармасьютикалз Ллс |
Аналоги 2'-хлоронуклеозидов для инфекции вгс
|
EP2909223B1
(en)
|
2012-10-19 |
2017-03-22 |
Idenix Pharmaceuticals LLC |
Dinucleotide compounds for hcv infection
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
WO2014078427A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
US9428512B2
(en)
|
2012-11-20 |
2016-08-30 |
Glaxosmithkline Llc |
Compounds
|
HUE13857477T2
(hu)
|
2012-11-20 |
2018-05-28 |
Glaxosmithkline Llc |
Új vegyületek
|
ES2632448T3
(es)
|
2012-11-20 |
2017-09-13 |
Glaxosmithkline Llc |
Nuevos compuestos
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
RS61767B1
(sr)
|
2012-12-21 |
2021-05-31 |
Janssen Biopharma Inc |
4'-fluor-nukleozidi, 4'-fluor-nukleotidi i njihovi analozi za lečenje hcv
|
WO2014120981A1
(en)
|
2013-01-31 |
2014-08-07 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
WO2014121417A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
WO2014121418A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
RU2534613C2
(ru)
*
|
2013-03-22 |
2014-11-27 |
Александр Васильевич Иващенко |
Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
WO2014169280A2
(en)
|
2013-04-12 |
2014-10-16 |
Achillion Pharmaceuticals, Inc. |
Deuterated nucleoside prodrugs useful for treating hcv
|
KR20160039154A
(ko)
*
|
2013-05-16 |
2016-04-08 |
리보사이언스 엘엘씨 |
4''-아자이도-3''-데옥시-3''-플루오로 치환된 뉴클레오시드 유도체
|
WO2014197578A1
(en)
|
2013-06-05 |
2014-12-11 |
Idenix Pharmaceuticals, Inc. |
1',4'-thio nucleosides for the treatment of hcv
|
ES2685591T3
(es)
|
2013-06-26 |
2018-10-10 |
Alios Biopharma, Inc. |
Nucleósidos, nucleótidos sustituidos y análogos de los mismos
|
EP3027636B1
(en)
|
2013-08-01 |
2022-01-05 |
Idenix Pharmaceuticals LLC |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
PL3038601T3
(pl)
|
2013-08-27 |
2020-08-24 |
Gilead Pharmasset Llc |
Formulacja złożona dwóch związków przeciwwirusowych
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2015054465A1
(en)
|
2013-10-11 |
2015-04-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
WO2015066370A1
(en)
|
2013-11-01 |
2015-05-07 |
Idenix Pharmaceuticals, Inc. |
D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
US20170198005A1
(en)
|
2013-11-27 |
2017-07-13 |
Idenix Pharmaceuticals Llc |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
US10683321B2
(en)
*
|
2013-12-18 |
2020-06-16 |
Idenix Pharmaceuticals Llc |
4′-or nucleosides for the treatment of HCV
|
EA033866B1
(ru)
|
2014-02-06 |
2019-12-03 |
Рибосайенс Ллк |
4'-дифторметилзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гриппа
|
AU2015217221A1
(en)
|
2014-02-13 |
2016-08-11 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
US20170135990A1
(en)
|
2014-03-05 |
2017-05-18 |
Idenix Pharmaceuticals Llc |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
WO2015161137A1
(en)
|
2014-04-16 |
2015-10-22 |
Idenix Pharmaceuticals, Inc. |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
WO2016003812A1
(en)
|
2014-07-02 |
2016-01-07 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and uses therof
|
JP6671355B2
(ja)
*
|
2014-09-26 |
2020-03-25 |
リボサイエンス・エルエルシー |
呼吸器多核体ウイルスのrna複製の阻害剤としての4’‐ビニル置換ヌクレオシド誘導体
|
MA41213A
(fr)
*
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
EP3236972B1
(en)
|
2014-12-26 |
2021-07-28 |
Emory University |
Anti-viral n4-hydroxycytidine derivatives
|
WO2016115222A1
(en)
*
|
2015-01-14 |
2016-07-21 |
Riboscience Llc |
4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
|
IL302877A
(en)
|
2015-03-06 |
2023-07-01 |
Atea Pharmaceuticals Inc |
Cell-D-2'-deoxy-2'-alpha-fluoro-2'-cell-C-modified-2-different-N6-purine modified nucleotides for the treatment of hepatitis C virus
|
KR101747314B1
(ko)
|
2015-07-01 |
2017-06-15 |
건국대학교 산학협력단 |
이중형광마커 형질전환 마우스를 이용한 만능줄기세포 구별방법
|
JP6767011B2
(ja)
*
|
2015-09-18 |
2020-10-14 |
ヤマサ醤油株式会社 |
抗dnaウィルス活性などの生理活性を有するヌクレオシド誘導体
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
KR20220146668A
(ko)
|
2016-09-07 |
2022-11-01 |
아테아 파마슈티컬즈, 인크. |
Rna 바이러스 치료를 위한 2'-치환된-n6-치환된 퓨린 뉴클레오티드
|
GEP20237457B
(en)
|
2017-02-01 |
2023-01-10 |
Atea Pharmaceuticals Inc |
Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
|
ES2969496T3
(es)
|
2017-08-01 |
2024-05-20 |
Gilead Sciences Inc |
Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
|
CA3082191C
(en)
|
2017-12-07 |
2021-09-21 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
JP2021509907A
(ja)
|
2018-01-09 |
2021-04-08 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
アセタール化合物およびその治療的使用
|
EP3773753A4
(en)
|
2018-04-10 |
2021-12-22 |
ATEA Pharmaceuticals, Inc. |
TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS
|
KR102073566B1
(ko)
|
2018-07-19 |
2020-02-05 |
한밭대학교 산학협력단 |
C형 간염 치료 및 예방용 조성물
|
CN109385459A
(zh)
*
|
2018-10-18 |
2019-02-26 |
大连理工大学 |
一种细胞分裂素通过抑制dna聚合酶活性抑制细胞增殖的方法
|
JP7233660B2
(ja)
*
|
2019-04-05 |
2023-03-07 |
株式会社日本触媒 |
架橋型人工ヌクレオシドの製造
|
TW202322824A
(zh)
|
2020-02-18 |
2023-06-16 |
美商基利科學股份有限公司 |
抗病毒化合物
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
CA3216162A1
(en)
|
2021-04-16 |
2022-10-20 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
CN113735927A
(zh)
*
|
2021-10-18 |
2021-12-03 |
厦门一先药业有限公司 |
一种核苷酸类似物及其制备方法和用途
|
TW202333706A
(zh)
|
2021-11-01 |
2023-09-01 |
德商埃慕尼克股份公司 |
N—羥基胞磷膽鹼(citicoline)化合物的醫藥用途
|
WO2024015916A2
(en)
*
|
2022-07-13 |
2024-01-18 |
Thomas Jefferson University |
4'-alkyne-2'-deoxycytidine-based compounds and anti-cancer uses thereof
|